Mrsa Treatment | MRSA Treatment Company ImmuVen Raising Money For Pre-IND Meeting

An Illinois company developing a way to stop superbugs like MRSA is raising capital that would take it into earliest stages of the drug approval process.

ImmuVen is developing a line of T cell receptor-related drugs . At first, the treatment will focus on infectious viral diseases such as methicillin-resistant Staphylococcus aureus (MRSA), which ImmuVen says it can halt by stopping the toxins secreted by MRSA. But the company also thinks that it can go beyond superbugs and use its technology to fight cancer.

The University of Illinois spinoff disclosed in a recent SEC filing that it had raised $250,000 and could continue to raise an unspecified amount of money. “Financially, we’re in the middle of a

Click here to view rest of article from original site

Honeymark First Aid Antiseptic Lotion, 2-ounce Plastic Jar  by Honeymark First Aid Antiseptic Lotion, 2-ounce Plastic Jar  by
7 new from $17.00
'no Magic Bullet' Among Mrsa Treatments.(dermatol... Therapy): An Article From: ‘no Magic Bullet’ Among Mrsa Treatments.(dermatol… Therapy): An Article From:
kin & Allergy News  by Kerri Wachter

Facebook Twitter Email